Bioactive Compounds
-
B2284 Fostamatinib (R788)1 CitationTarget: SykSummary: Spleen tyrosine kinase (Syk) inhibitor -
B1426 Org 27569Target: CB1 ReceptorsSummary: Cannabinoid CB1 receptor allosteric modulator -
B1536 AZD10801 CitationTarget: GSK-3Summary: GSK3βinhibitor -
B1628 MPEPSummary: MGlu5 receptor antagonist -
B1926 Dexamethasone acetateTarget: Glucocorticoid Receptors|interleukin receptorSummary: IL Receptor modulator -
B1627 (-)-MK 801Target: NMDA ReceptorsSummary: NMDA antagonist,potent and selective -
B1102 BrexpiprazoleSummary: 5-HT2A, α1B-, and α2C-adrenergic receptors antagonist -
B1531 (R)-baclofenTarget: GABAB ReceptorsSummary: GABA receptor agonist -
B2110 Meptazinol HClSummary: Partial agonist at the μ1 opioid receptor -
B1123 RosuvastatinSummary: Competitive inhibitor of HMG-CoA reductase
